h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Naming Tool
Publishing your line
Structures & Partners
Registration Summary
Certification
API
Export Data
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
GIBHi004-A
Registration Summary
:
A
P
E
C
PARK7-L10P-C2
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg Name
A standardised name that was automatically generated based on the cell line information. see
Naming Tool
GIBHi004-A
Alternative name(s)
PARK7-L10P-C2
Cell line type
Human induced pluripotent stem cell (hiPSC)
Last update
24th December 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
Contact:
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
Owner
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
Distributors
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
External Databases
BioSamples
SAMEA6592712
Cellosaurus
CVCL_YT02
Wikidata
Q93561149
General Information
Publications
Li Y et al. Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P). Stem cell research. 2020 Jul;46:101845.
Yao L et al. Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements. Frontiers in cell and developmental biology. 2021;9:655819.
Kim J et al. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease. Genes. 2022 Oct 25;13(11).
* Is the cell line readily obtainable for third parties?
Yes
Research use:
allowed
Clinical use:
not allowed
Commercial use:
not allowed
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.